Reversible Posterior Leukoencephalopathy in the Course of Goodpasture Syndrome

dc.authorid0000-0001-9905-4305
dc.authorid0000-0001-5943-0302
dc.contributor.authorÖzkök, Abdullah
dc.contributor.authorElçioğlu, Ömer Celal
dc.contributor.authorBakan, Ali
dc.contributor.authorAtilgan, Kadir Gokhan
dc.contributor.authorAlisir, Sabahat
dc.contributor.authorOdabaş, Ali Riza
dc.date.accessioned2025-05-10T19:36:18Z
dc.date.issued2012
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractReversible posterior leukoencephalopathy syndrome (RPLS) is characterized by headache, altered consciousness, seizures, and cortical blindness. The most frequent etiological factors are hypertension, kidney diseases, and immunosuppressive drugs such as steroids and cyclophosphamide. Herein we present a case of a 22-year-old female patient presented with alveolar hemorrhage and acute renal failure necessitating hemodialysis. In renal biopsy, necrotizing crescentic glomerulonephritis and immunofluorescence pattern compatible with Goodpasture syndrome were found. Anti-glomerular basement membrane antibody result was positive. At follow-up, respiratory failure ensued, steroid pulse treatment was started, and she was transferred to intensive care unit (ICU). In the ICU, she had visual disturbances and blindness together with seizures. Cranial magnetic resonance imaging (MRI) revealed irregular T2- and fluid-attenuated inversion recovery (FLAIR)-weighted lesions in bilateral occipital lobes. On clinical and radiological grounds, RPLS was diagnosed. With the supportive and anti-hypertensive treatment, RPLS was resolved without a sequela. Subsequent cranial MRI was totally normal. In the literature, RPLS associated with Goodpasture syndrome was reported only once. Hypertension and methylprednisolone might be the responsible etiologies in this case.
dc.identifier.doi10.3109/0886022X.2011.647211
dc.identifier.endpage256
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.issue2
dc.identifier.pmid22251235
dc.identifier.scopus2-s2.0-84856647084
dc.identifier.scopusqualityQ2
dc.identifier.startpage254
dc.identifier.urihttps://doi.org/10.3109/0886022X.2011.647211
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9149
dc.identifier.volume34
dc.identifier.wosWOS:000299784400022
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofRenal Failure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectreversible posterior leukoencephalopathy syndrome
dc.subjectGoodpasture syndrome
dc.subjecthypertension
dc.subjectcorticosteroids
dc.titleReversible Posterior Leukoencephalopathy in the Course of Goodpasture Syndrome
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9149.pdf
Boyut:
1.54 MB
Biçim:
Adobe Portable Document Format